In this work we focus on the imaging of magnetic nanoparticles in tumor tissue. The spatial distribution of magnetic nanoparticles in tumor tissue is an essential parameter in the evaluation of the efficiency of magnetic drug targeting (MDT). We developed a volume-based imaging method for x-ray-micro tomography calibrated by magnetorelaxometry to determine the concentration of magnetic nanoparticles in a certain tissue. With this technique, the x-ray absorption information contained in a μ-CT image can be directly related to an absolute mass of magnetic nanoparticles in a certain volume element of the tumor. In contrast to other related methods reported in the literature, the procedure described here is capable of a mass resolution of 0.044 μg mm −3
Introduction
Magnetic nanoparticles open up many possibilities for medical applications. Among them magnetic drug targeting (MDT) is one of the most promising approaches . The guided enrichment of particles with bound chemotherapeutic agents gives a competitive edge for this therapeutic approach due to the fact that the systemic toxicity of anticancer drugs is diminished (Pankhurst et al 2003) , offering cancer patients a less exhausting but successful therapy. The efficacy of MDT depends on achieving a high concentration of nanoparticles in a homogeneous distribution inside the tumor. Therefore a detailed understanding of the distribution and enrichment in the targeted tumor tissue is necessary.
The standard procedure for quantitative detection of magnetic nanoparticles in tissue is the histological evaluation of Prussian blue stained sections (Romeis 2010) . The disadvantage of this procedure is the incomplete information obtained about the spatial distribution of the particles inside a tissue sample, as the necessary high number of sections cannot be prepared effectively.
Other methods for detecting particles in tissue, such as magnetorelaxometry (MRX) or x-ray-μ-tomography, provide either a high resolution of the mass content of magnetic nanoparticles combined with a low spatial resolution (MRX), or a spatial resolution in the μm range combined with a mass resolution of only a few mg in the evaluated volume element Odenbach 2009, Rahn et al 2012) . Thus both techniques offer only part of the necessary information. Since many experiments using animal models for MDT employ only a small amount of magnetic particles (He et al 2013) , the above-mentioned methods cannot be used to obtain the required spatial distribution with an adequate resolution in space and particle amount. This is especially the case for mouse models as they are used in the present study. In such tumor samples, a mass content of about 100-360 μg magnetic nanoparticles for a complete tumor with a size about 100-350 mm 3 is found (Balivada et al 2010) . Based on the assumption of a homogeneous distribution, the mean concentration of magnetic particles will be on the order of about 1 μg mm −3
. Considering the aim of a quantitative analysis of particle distribution in such samples, a mass resolution able to detect differences of about 0.05 μg mm −3 is required.
In order to achieve the necessary spatial and mass resolution, we calibrated X-μCT images with quantitative mass data obtained by MRX, using complete tumors with a mostly homogeneous particle distribution as calibration samples.
Experimental setup

Mouse model
The investigation of nanoparticle imaging was performed in a mouse model. Young male nu/nu mice were chosen as hosts for transplanted FaDu tumor tissue. Nu/nu mice are hairless and often used in medical experiments because of their hereditary immune deficiency from the aplastic thymus (Pantelouris and Hair 1970). The missing function of this lymphoid organ enables the transplantation of allogeneic grafts, since there is no host-versus-graft reaction from the immune system.
FaDu is a human squamous cell carcinoma, that was discovered in 1968 (Rangan 1972) and was added to the American Type Culture Collection, Rockville, Maryland. In 1990, this cell line was established in the radio biological research laboratory of the University Hospital Carl Gustav Carus Dresden, Department of Radiation Oncology and Radiotherapy (Eicheler et al 2002) . FaDu tumor tissue from the cryopopulation was transplanted subcutaneously onto the hind leg of the nude mice. This experimental setup was approved by the local animal protection authorities (Landesdirektion Sachsen, reference number 24-9168.11-1/2012-5).
Magnetic fluid and application
The ferrofluid FluidMAG DX produced by chemicell (Berlin) was used to perform the experiment and consists of a core of maghemite surrounded by surfactant dextrane molecules. Two different hydrodynamic particle sizes, 50 nm and 100 nm, were applied.
After the tumor grew to the required size of 7 mm diameter the mouse was included in the experiment. Depending on the experimental group, the ferrofluid was either directly injected into the tumor or was provided via the tumor-supplying femoral artery.
The mice were anesthetized with Xylazin/Ketamin before the injection of the ferrofluid. For intraarterial injection the femoral artery was dissected. The puncture of the artery was performed under a light microscope. Adhesive tape was used to immobilize the anesthetized mice lying on their backs with the leg abducted and slightly laterally rotated. After a small skin incision in the groin, the soft tissue was separated with a medical cotton swab and small tweezers until the femoral artery was found. The ferrofluid was injected as slowly as possible with a one-way insulin syringe (Omnican 40, U-40 Insulin Braun©). Afterwards the cotton swab was used for hemostasis, and the wound was cleaned.
Both groups, intra-tumoral and intra-arterial injection, were divided into two subgroups each, which were treated with 0.2 ml of FluidMAG DX either containing 50 nm particles (concentration of 100 mg ml ). A total of 15 mice were included. One mouse was treated as a negative control (without any injection of ferrofluid), 8 mice were treated with 100 nm particles and 6 mice were treated with 50 nm particles. Two mice of each particle size group were treated with intra-tumoral injection, while the others were treated intra-arterially. 2 min after the injection the mouse was sacrificed. For further investigation the tumor was resected, fixed in formaline and embedded in paraffin. Since the injected volume appeared quite high relative to the weight of the mice (35-48 g), their level of tolerance for the solution was confirmed in a separate investigation. No impairment of health or lethal complications were observed.
μ-Computertomography
The tumor samples were measured with the X-μCT scanner LeTo (Chair of Magnetofluiddynamics, Technische Universität Dresden) . The scan was performed with the following parameters: acceleration voltage 50 kV, anode current 0.998 mA, resolution 56 μm, filter 0.5 mm aluminum. Afterwards the data sets were reconstructed with VG Studio Max 2.1.
Magnetorelaxometry
MRX is a very sensitive method for the specific detection of magnetic nanoparticles with a resolution of several nanograms. However, the spatial resolution is comparatively low in ranges of centimeters to a few millimeters depending on the kind of magnetic nanoparticles and their characteristics . MRX is based on the detection of the relaxation of magnetic nanoparticles immediately after the removal of a small magnetizing field (2 mT). The nanoparticles contain a magnetic moment with random orientation in the absence of an external magnetic influence. In an external magnetic field, the magnetic moments align and sum to a measurable magnetization. When this external field is switched off, the particles will relax within a measurable lag time and fall back into a randomly distributed orientation with no measurable magnetization.
The relaxation signal is linearly proportional to the amount of (incorporated) magnetic nanoparticles (Eberbeck et al 2006) . The quantification is accomplished by using a reference sample of the same nanoparticle type with a known particle amount. The MRX measurements were performed at Physikalisch-Technische Bundesanstalt in Berlin.
Histological investigation
Histological investigation is a standard procedure to examine tissue. In the present study it provides a reliable assessment of the accumulation and distribution of the nanoparticles in the tumor tissue. Therefore, four tumors were chosen for histological sections and staining in Prussian Blue. This is a special staining for detecting Fe 3+ (Romeis 2010) , in which, as shown in figure 1 , the iron cores of nanoparticles appear as blue spots surrounded by pinkish cells.
Analysis of μ-CT data
An essential part of the analytic process is the calibration shown in figure 2. A software program, developed specially for this purpose in the python programming language, was used to work with the reconstructed μ-CT data sets. In the first step the data was stored in a 3D-matrix representation in which different mathematical operations can be applied directly to the volume.
The average gray value of an acrylic block (200 mm 3 ) in the scan and the gray value of an equally sized volume of air were determined. These two points were used to set the same base level for all measurements. In the next step a cuboid with the tumor and the surrounding embedded material was cut out and separated from the remaining scene. To enable the investigation of the tumor itself another separation step followed. After a rough estimation of the tumor volume through a cut-off value, erosion-and dilatation filters were used to identify the exact tumor boundary. Even with the calibration of the dataset against acrylic and air small variations of the mean gray value (MGV) of the paraffin surrounding the tumor could be found. Because of the density of this surrounding area is comparable to that of the subject of investigation, the complete dataset was scaled to a common value for paraffin of 31 300. From the voxel count inside the tumor, its volume was determined and used to obtain the nanoparticle concentration with the corresponding MRX measurements. All values of the tumor voxels were merged into the MGV.
Results and discussion
To enable a quantitative analysis of the data collected by μCT a relation between the MGV of the tumor and the corresponding nanoparticle concentration had to be established. Therefore the obtained MGVs for the different tumors with 100 nm particles were plotted against the nanoparticle concentration as obtained by MRX as blue triangles in figure 3 . A linear regression line was fitted to the data (R . The calculated relative error of the concentration caused by the calibration function is 20%.
Furthermore, figure 3 shows the comparison between the μCT-calculated and MRX-measured concentrations. The deviation is represented by the distance of the blue triangles from the calibration function which also embodies the optimum match. Tumors with low concentrations show higher deviations from the calibration function compared to tumors with higher concentrations. Because of lower divergences in the high concentration area, deviations of tumors with concentrations above 800 g m −3 were calculated separately. This results in a deviation of ±164 g m −3 in the high concentration part compared to a value of ±247 g m −3 for the low concentration part. This can be explained by the fact, that xenograft tumors only contain a small amount of particles in the range of 30-300 μg of nanoparticles. Especially for the tumors with lower concentration, the error of the determination of the gray values in X-μCT scans becomes larger, leading to the observed uncertainties. In addition, the procedure of extracting the tumor volume is sensitive and therefore prone to miscalculation. Little mistakes might cause a higher deviation during the assessment, especially for very small tumors with low particle content, since for these the MGV is comparably close to that of paraffin, and thus a small deviation from the correct volume through the cut-off process can cause noticeable deviations. In the actual status we obtained a calibration function that shows, that a quantitative evaluation of magnetic particle concentration in tissue for very low concentration is possible. In future research, when the number of tumors investigated will be increased to achieve medical relevant statistics, an improvement of the calibration curve can be achieved by using more tumor samples for the determination of the calibration function. Overall 9 tumors with 100 nm particles were used to define the calibration function. Because their relaxations times were too fast, tumors treated with 50 nm particles could not be quantified with MRX.
To determine the amount of particles in those tumor samples, the calibration function defined with the samples containing 100 nm particles was employed. This approach can be used because single nanoparticles themselves cannot be seen in X-μCT; rather, the MGV indicates amounts of accumulated particles. For the validation of the procedure, a similar behavior of accumulation and distribution of the different-sized particles in the tumor tissue had to be proven. Both particle sizes were expected to behave in the same manner: however, the possibility that 50 nm particles might be taken up more easily by tumor cells or might penetrate more readily through the endothelium could not be excluded. Therefore, histological investigations were performed. As shown in figures 1(a) and (b) lower concentrations of both types of particles particularly accrued in blood vessels and the surrounding connective tissue. Higher concentrations, as shown in the lower part of figures 1(c) and (d), infiltrate the matrix between the FaDu cells. Since no difference in the results of the quantitative evaluation of histology could be observed, the tumors treated with 50 nm particles can be quantified with the calibration function introduced above.
In table 1, the results of the quantification of the tumors treated with 50 nm particles is presented. The potential divergence of the calculated value from the real amount was computed by averaging the deviations of the tumors treated with 100 nm particles. As ; which is supported by an obviously high particle accumulation seen in the histological sections. Especially the area of the injection as shown in figure 5(c) contains a high amount of particles which also spreads in the surrounding area as seen in 1d. For this experiment, the ferrofluid was directly injected into the tumor and therefore the loss of particles to systemic circulation is lower compared to the intra-arterial application. On the other hand, Tumor 14 in figure 1(b) shows only a small accumulation of particles in histological sections, which corresponds well to the calculated concentration of 0.424 μg mm . The low concentration of nanoparticles in tumors treated intra-arterially could be increased by using MDT (Alexiou et al 2011) . However, blood circulation and tumor vascularization are essential parameters for particle accumulation that vary from sample to sample. This might be an explanation for the variety of concentrations between 300 g m −3 to 2400 g m −3 in the intra-arterially treated group.
Conclusion
Our investigations focused on determining the amount of nanoparticles incorporated in a xenograft tumor. We combined two standard measurement techniques, MRX and x-ray-μ-tomography. The results show a new option for the quantification of magnetic nanoparticles with both high spatial distribution and with a high mass resolution. The method developed here enables the quantification of low amounts of magnetic particles as well as the quantification of fast relaxing nanoparticles, such as the 50 nm FluidMAG DX used here. Furthermore, due to the high concentration resolution, the particle distribution in the tumor can be quantitatively visualized and evaluated in a 3D representation as shown in figure 5 . Since the procedure was only confirmed on tumors transplanted onto mice, it would be of great interest to expand this method in further research to tumors of bigger size with higher particle content.
